WHO ICTRP trial
Randomised comparison of chloroquine plus sulfadoxine-pyrimethamine versus…
ISRCTN75303340 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN75303340 |
|---|---|
| Public title | Randomised comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic |
| Primary sponsor | University of Oxford (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Laos |
| Conditions | Malaria Infections and Infestations Malaria |
| Interventions | A randomised comparison of three oral antimalarial combinations. 1. Chloroquine plus sulfadoxine-pyrimethamine 2. Artesunate plus mefloquine 3. Artemether-lumefantrine 42-day follow-up period. |
| Registration date | Jul 22, 2005 |
| Target size | 330 |
| Secondary IDs | 065146 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: